1.Atypical Paroxysmal Kinesigenic Dyskinesia with Paroxysmal Exercise-induced Dyskinesia
Suin LEE ; Jae Rim KIM ; Young-Kyun KIM ; Hyoeun BAE ; Soo Ryun PARK ; Kyungmin KIM ; Ki Hyun KIM ; Jung Seok LEE ; Dae-Won SEO
Journal of the Korean Neurological Association 2024;42(1):66-70
		                        		
		                        			
		                        			 Paroxysmal kinesigenic dyskinesia (PKD) is a diagnostic term for transient, involuntary abnormal movements triggered by sudden motions. The treatment for PKD differs from other paroxysmal dyskinesias, as it notably responds well to sodium channel blockers. We report a case of atypical PKD, coupled with paroxysmal exercise-induced dyskinesia (PED). Both PKD and PED in this patient showed a good response to oxcarbazepine. This case could be clinical evidence that paroxysmal dyskinesias could potentially be regarded as a spectrum disorder with overlapping features. 
		                        		
		                        		
		                        		
		                        	
2.Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in Korea
Seo-Yeon AHN ; Sang Kyun SON ; Gyu Hyung LEE ; Inho KIM ; June-Won CHEONG ; Won Sik LEE ; Byung Soo KIM ; Deog-Yeon JO ; Chul Won JUNG ; Chu Myoung SEONG ; Jae Hoon LEE ; Young Jin YUH ; Min Kyoung KIM ; Hun-Mo RYOO ; Moo-Rim PARK ; Su-Hee CHO ; Hoon-Gu KIM ; Dae Young ZANG ; Jinny PARK ; Hawk KIM ; Seryeon LEE ; Sung-Hyun KIM ; Myung Hee CHANG ; Ho Sup LEE ; Chul Won CHOI ; Jihyun KWON ; Sung-Nam LIM ; Suk-Joong OH ; Inkyung JOO ; Dong-Wook KIM
Blood Research 2022;57(2):144-151
		                        		
		                        			 Background:
		                        			Nilotinib is a tyrosine kinase inhibitor approved by the Ministry of Food and Drug Safety for frontline and 2nd line treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). This study aimed to confirm the safety and efficacy of nilotinib in routine clinical practice within South Korea. 
		                        		
		                        			Methods:
		                        			An open-label, multicenter, single-arm, 12-week observational post-marketing surveillance (PMS) study was conducted on 669 Korean adult patients with Ph + CML from December 24, 2010, to December 23, 2016. The patients received nilotinib treatment in routine clinical practice settings. Safety was evaluated by all types of adverse events (AEs) during the study period, and efficacy was evaluated by the complete hematological response (CHR) and cytogenetic response. 
		                        		
		                        			Results:
		                        			During the study period, AEs occurred in 61.3% (410 patients, 973 events), adverse drug reactions (ADRs) in 40.5% (271/669 patients, 559 events), serious AEs in 4.5% (30 patients, 37 events), and serious ADRs in 0.7% (5 patients, 8 events). Furthermore, unexpected AEs occurred at a rate of 6.9% (46 patients, 55 events) and unexpected ADRs at 1.2% (8 patients, 8 events). As for the efficacy results, CHR was achieved in 89.5% (442/494 patients), and minor cytogenetic response or major cytogenetic response was achieved in 85.8% (139/162 patients). 
		                        		
		                        			Conclusion
		                        			This PMS study shows consistent results in terms of safety and efficacy compared with previous studies. Nilotinib was well tolerated and efficacious in adult Korean patients with Ph + CML in routine clinical practice settings. 
		                        		
		                        		
		                        		
		                        	
3.A course on endovascular training for resuscitative endovascular balloon occlusion of the aorta: a pilot study for residents and specialists
Ye Rim CHANG ; Chan Yong PARK ; Dong Hun KIM ; Dae Sung MA ; Sung Wook CHANG
Annals of Surgical Treatment and Research 2020;99(6):362-369
		                        		
		                        			 Purpose:
		                        			Resuscitative endovascular balloon occlusion of the aorta (REBOA) has emerged as a salvage technique changing the paradigm in the management of noncompressible torso hemorrhage. However, training for the REBOA procedure is rarely performed. The endovascular training for REBOA (ET-REBOA) course was conducted to develop the endovascular skills of participants. 
		                        		
		                        			Methods:
		                        			Sixteen residents and 12 specialists participated in this educational course. All participants were provided with precourse learning materials. The ET-REBOA course consisted of 2 sections; an ultrasound-guided sheath insertion on the puncture model, and a balloon manipulation on the vascular circuit model. A 13-item procedure checklist and the time required to perform the procedure were examined. Pre/post self-reported confidence score and course satisfaction questionnaire were obtained. 
		                        		
		                        			Results:
		                        			Twenty-eight participants performed the 56 REBOA procedures. On the first attempt, the median total time for REBOA from ultrasound-guided vascular access to balloon inflation was 1,139 ± 250 seconds in the resident group and 828 ± 280 seconds in the specialist group. The median shortened time for completion was 273 seconds and 290 seconds respectively. A significant decrease in procedure task time was observed between first and second attempts in the resident group (P = 0.016), specialist group (P = 0.004), and in total among all participants (P < 0.001). 
		                        		
		                        			Conclusion
		                        			The ET-REBOA course significantly decreased the time taken to perform the REBOA procedure with high satisfaction of the participants. The course could be an effective curriculum for the development of endovascular skills for performing REBOA. 
		                        		
		                        		
		                        		
		                        	
4.The first case of vaginal angiomatoid Spitz nevus causing vaginal bleeding
Yong Hee PARK ; Jung Mi BYUN ; Hwa Jin CHO ; Dae Hoon JEONG ; Young Nam KIM ; Hye Rim PARK ; Kyung Bok LEE ; Moon Su SUNG
Obstetrics & Gynecology Science 2019;62(4):290-293
		                        		
		                        			
		                        			Angiomatoid Spitz nevus is a variant of melanocytic nevus with prominent vasculature. Due to its pathologic features, angiomatoid Spitz nevus in the vaginal wall is extremely rare. A 42-year-old woman presented to the hospital with abnormal vaginal bleeding. Vaginal examination revealed a 2×2-cm well-demarcated tumor on the posterior wall of the vagina. The mass was successfully removed by complete excision and was diagnosed as angiomatoid Spitz nevus on pathologic examination. We present the first reported case of vaginal angiomatoid Spitz nevus, which caused vaginal bleeding. Although angiomatoid Spitz nevus has many histopathological similarities with malignant melanoma, precise histopathological diagnosis is important for preventing overtreatment.
		                        		
		                        		
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Diagnosis
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Gynecological Examination
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Medical Overuse
		                        			;
		                        		
		                        			Melanoma
		                        			;
		                        		
		                        			Nevus, Epithelioid and Spindle Cell
		                        			;
		                        		
		                        			Nevus, Pigmented
		                        			;
		                        		
		                        			Uterine Hemorrhage
		                        			;
		                        		
		                        			Vagina
		                        			
		                        		
		                        	
5.Successful development of squamous cell carcinoma and hyperplasia in RGEN-mediated p27 KO mice after the treatment of DMBA and TPA.
Jun Young CHOI ; Woo Bin YUN ; Ji Eun KIM ; Mi Rim LEE ; Jin Ju PARK ; Bo Ram SONG ; Hye Ryeong KIM ; Ji Won PARK ; Mi Ju KANG ; Byeong Cheol KANG ; Han Woong LEE ; Dae Youn HWANG
Laboratory Animal Research 2018;34(3):118-125
		                        		
		                        			
		                        			To evaluate the carcinogenicity of p27 knockout (KO) mice with RNA-guided endonuclease (RGENs)-mediated p27 mutant exon I gene (IΔ), alterations in the carcinogenic phenotypes including tumor spectrum, tumor suppressor proteins, apoptotic proteins and cell cycle regulators were observed in p27 (IΔ) KO mice after treatment with 7,12-Dimethylbenz[a]anthracene (DMBA) and 12-O-tetradecanoylphorbol-13-acetate (TPA)(DT) for 5 months. The target region (544~571 nt) in exon I of the p27 gene was successfully disrupted in p27 (IΔ) KO mice using the RGEN-induced non-homologous end joining (NHEJ) technique. After DT exposure for 5 months, a few solid tumors (identified as squamous cell carcinoma) developed on the surface of back skin of DT-treated p27 (IΔ) KO mice. Also, squamous cell hyperplasia with chronic inflammation was detected in the skin dermis of DT-treated p27 (IΔ) KO mice, while the Vehicle+p27 (IΔ) KO mice and WT mice maintained their normal histological skin structure. A significant increase was observed in the expression levels of tumor suppressor protein (p53), apoptotic proteins (Bax, Bcl-2 and Caspase-3) and cell-cycle regulator proteins (Cyclin D1, CDK2 and CDK4) in the skin of DT-treated p27 (IΔ) KO mice, although their enhancement ratio was varied. Taken together, the results of the present study suggest that squamous cell carcinoma and hyperplasia of skin tissue can be successfully developed in new p27 (IΔ) KO mice produced by RGEN-induced NHEJ technique following DT exposure for 5 months.
		                        		
		                        		
		                        		
		                        			9,10-Dimethyl-1,2-benzanthracene*
		                        			;
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Carcinogenesis
		                        			;
		                        		
		                        			Carcinoma, Squamous Cell*
		                        			;
		                        		
		                        			Cell Cycle
		                        			;
		                        		
		                        			Dermis
		                        			;
		                        		
		                        			Epithelial Cells*
		                        			;
		                        		
		                        			Exons
		                        			;
		                        		
		                        			Hyperplasia*
		                        			;
		                        		
		                        			Inflammation
		                        			;
		                        		
		                        			Mice*
		                        			;
		                        		
		                        			Phenotype
		                        			;
		                        		
		                        			Skin
		                        			;
		                        		
		                        			Tumor Suppressor Proteins
		                        			
		                        		
		                        	
6.Dose dependence and durability of the therapeutic effects of Asparagus cochinchinensis fermented extract in an ovalbumin-challenged asthma model.
Jun Young CHOI ; Ji Won PARK ; Ji Eun KIM ; Jin Ju PARK ; Mi Rim LEE ; Bo Ram SONG ; Mi Ju KANG ; Dae Youn HWANG
Laboratory Animal Research 2018;34(3):101-110
		                        		
		                        			
		                        			The butanol extract of Asparagus cochinchinensis roots fermented with Weissella cibaria (BAfW) significantly suppressed the inflammatory response induced by lipopolysaccharide (LPS) treatment in RAW264.7 cells. To investigate the dose dependence and durability of BAfW on the anti-asthma effects, alterations in key parameters were measured in ovalbumin (OVA)-challenged Balb/c mice treated with the different doses of BAfW at three different time points. The number of immune cells, OVA-specific IgE level, thickness of respiratory epithelium and mucus score decreased significantly in a dose-dependent manner in response to treatment with 125 to 500 mg/kg BAfW (P < 0.05), although the highest level was detected in the 500 mg/kg treated group. Moreover, the decrease in these parameters was maintained from 24 to 48 h in the 500 mg/kg of BAfW treated group. At 72 h, the effects of BAfW on the number of immune cells, OVA-specific IgE level and thickness of respiratory epithelium partially disappeared. Overall, this study provides the first evidence that the anti-asthma effect of BAfW may reach the maximum level in OVA-challenged Balb/c mice treated with 500 mg/kg and that these effects can last for 48 h.
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Asthma*
		                        			;
		                        		
		                        			Fermentation
		                        			;
		                        		
		                        			Immunoglobulin E
		                        			;
		                        		
		                        			Mice
		                        			;
		                        		
		                        			Mucus
		                        			;
		                        		
		                        			Ovalbumin
		                        			;
		                        		
		                        			Respiratory Mucosa
		                        			;
		                        		
		                        			Therapeutic Uses*
		                        			;
		                        		
		                        			Weissella
		                        			
		                        		
		                        	
7.Inhibition of endoplasmic reticulum stress in high-fat-diet-induced obese C57BL/6 mice: Efficacy of a novel extract from mulberry (Morus alba) leaves fermented with Cordyceps militaris.
Mi Rim LEE ; Su Ji BAE ; Ji Eun KIM ; Bo Ram SONG ; Jun Young CHOI ; Jin Ju PARK ; Ji Won PARK ; Mi Ju KANG ; Hyeon Jun CHOI ; Young Whan CHOI ; Kyung Mi KIM ; Dae Youn HWANG
Laboratory Animal Research 2018;34(4):288-294
		                        		
		                        			
		                        			A few clues about correlation between endoplasmic reticulum (ER) stress and mulberry (Morus alba) leaves were investigated in only the experimental autoimmune myocarditis and streptozotocin-induced diabetes. To investigate whether a novel extract of mulberry leaves fermented with Cordyceps militaris (EMfC) could suppress ER in fatty liver, alterations in the key parameters for ER stress response were measured in high fat diet (HFD)-induced obese C57L/6 mice treated with EMfC for 12 weeks. The area of adipocytes in the liver section were significantly decreased in the HFD+EMfC treated group as compared to the HFD+Vehicle treated group, while their level was higher in HFD+Vehicle treated group than No treated group. The level of the eukaryotic initiation factor 2 alpha (eIF2α) and inositol-requiring enzyme 1 beta (IRE1α) phosphorylation and CCAAT-enhancer-binding protein homologous protein (CHOP) expression were remarkably enhanced in the HFD+Vehicle treated group. However, their levels were restored in the HFD+EMfC treated group, although some differences were detected in the decrease rate. Similar recovery was observed on the ER stress-induced apoptosis. The level of Caspase-3, Bcl-2 and Bax were decreased in the HFD+EMfC and HFD+orlistat (OT) treated group compared to the HFD+Vehicle treated group. The results of the present study therefore provide first evidence that EMfC with the anti-obesity effects can be suppressed ER stress and ER stress-induced apoptosis in the hepatic steatosis of HFD-induced obesity model.
		                        		
		                        		
		                        		
		                        			Adipocytes
		                        			;
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Apoptosis
		                        			;
		                        		
		                        			Caspase 3
		                        			;
		                        		
		                        			CCAAT-Enhancer-Binding Proteins
		                        			;
		                        		
		                        			Cordyceps*
		                        			;
		                        		
		                        			Diet, High-Fat
		                        			;
		                        		
		                        			Endoplasmic Reticulum Stress*
		                        			;
		                        		
		                        			Endoplasmic Reticulum*
		                        			;
		                        		
		                        			Eukaryotic Initiation Factor-2
		                        			;
		                        		
		                        			Fatty Liver
		                        			;
		                        		
		                        			Liver
		                        			;
		                        		
		                        			Mice*
		                        			;
		                        		
		                        			Morus*
		                        			;
		                        		
		                        			Myocarditis
		                        			;
		                        		
		                        			Obesity
		                        			;
		                        		
		                        			Phosphorylation
		                        			
		                        		
		                        	
8.Regulation of gastrointestinal hormones during laxative activity of gallotannin-enriched extract isolated from Galla Rhois in loperamide-induced constipation of SD rats.
Ji Eun KIM ; Mi Ju KANG ; Jun Young CHOI ; Jin Ju PARK ; Mi Rim LEE ; Bo Ram SONG ; Hye Ryeong KIM ; Ji Won PARK ; Hyeon Jun CHOI ; Su Ji BAE ; Dae Youn HWANG
Laboratory Animal Research 2018;34(4):223-231
		                        		
		                        			
		                        			Regulation of gastrointestinal hormones have been reported in animal models for constipation undergoing laxative therapy when administered herbal products. We undertook to investigate whether the laxative activity of gallotannin-enriched extracts isolated from Galla Rhois (GEGR) affects the regulation of gastrointestinal hormones, by examining the concentration of four hormones and the activation of their receptors in the loperamide (Lop)-induced constipation model. Stool parameters, including number, weight and water content, were significantly recovered in the Lop+GEGR treated group, relative to the Lop+vehicle treated group; however, food intake and water consumption were maintained at a constant level. Also, a similar recovery was detected for thickness of mucosa, muscle and flat luminal surface in the Lop+GEGR treated group. Furthermore, concentration of the four gastrointestinal hormones evaluated, namely, cholecystokinin (CCK), gastrin (GAS), somatostatin (SS) and motilin (MTL), were lower in the Lop+vehicle treated group than the No treated group, but were remarkably enhanced in the Lop+GEGR treated group. Moreover, the downstream signaling pathway of MTL and SS receptors were recovered after GEGR administration. Results of the present study therefore indicate that the laxative effects of GEGR treatment may be tightly related with the regulation of gastrointestinal hormones in the Lop-induced constipation model.
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Cholecystokinin
		                        			;
		                        		
		                        			Constipation*
		                        			;
		                        		
		                        			Drinking
		                        			;
		                        		
		                        			Eating
		                        			;
		                        		
		                        			Gastrins
		                        			;
		                        		
		                        			Gastrointestinal Hormones*
		                        			;
		                        		
		                        			Loperamide
		                        			;
		                        		
		                        			Models, Animal
		                        			;
		                        		
		                        			Motilin
		                        			;
		                        		
		                        			Mucous Membrane
		                        			;
		                        		
		                        			Phenobarbital
		                        			;
		                        		
		                        			Rats*
		                        			;
		                        		
		                        			Somatostatin
		                        			;
		                        		
		                        			Water
		                        			
		                        		
		                        	
9.Therapeutic Effect of Microcurrent Therapy in Children With In-toeing Gait Caused by Increased Femoral Anteversion: A Pilot Study.
Jae Ki AHN ; Dong Rak KWON ; Gi Young PARK ; Ki Hoon LEE ; Jae Hwal RIM ; Won Bin JUNG ; Dae Gil KWON
Annals of Rehabilitation Medicine 2017;41(1):104-112
		                        		
		                        			
		                        			OBJECTIVE: To investigate the efficacy of portable microcurrent therapy device (PMTD) of the hip internal rotators in the treatment of in-toeing gait caused by increased femoral anteversion in children over 8 years of age. METHODS: Eleven children (22 legs; 4 boys and 7 girls; mean age, 10.4±1.6 years) with in-toeing gait caused by increased femoral anteversion were included in the present study. All children received 60 minutes of PMTD (intensity, 25 µA; frequency, 8 Hz) applied to the hip internal rotators daily for 4 weeks. Hip internal rotation (IR) angle, external rotation (ER) angle, and midmalleolar-second toe angle (MSTA) measurement during stance phase at transverse plane and Family Satisfaction Questionnaire, frequency of tripping and fatigue like pains about the PMTD were performed before treatment and at 4 weeks after initial PMTD treatment. Paired t-test and Fisher exact test were used for statistical analysis. RESULTS: Hip IR/ER/MSTA was 70.3°±5.4°/20.1°±5.5°/–11.4°±2.7°, and 55.7°±7.8°/33.6°±8.2°/–2.6°±3.8° before treatment and at 4 weeks after initial PMTD treatment, respectively (p<0.01). Ten of 11 (91%) children's family stated that they were generally satisfied with the PMTD treatment. The frequency of tripping and fatigue like pains was significantly lower at 4 weeks after PMTD treatment (p<0.05). Excellent inter-rater and intra-rater reliability was observed for repeated MSTA measurements between the examiners (k=0.91–0.96 and k=0.93–0.99), respectively. CONCLUSION: PMTD of the hip internal rotators can be effective in improving the gait pattern of children with in-toeing gait caused by increased femoral anteversion.
		                        		
		                        		
		                        		
		                        			Bone Anteversion
		                        			;
		                        		
		                        			Child*
		                        			;
		                        		
		                        			Electric Stimulation Therapy
		                        			;
		                        		
		                        			Fatigue
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Gait*
		                        			;
		                        		
		                        			Hip
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Leg
		                        			;
		                        		
		                        			Pilot Projects*
		                        			;
		                        		
		                        			Toes
		                        			
		                        		
		                        	
10.Comparison of therapeutic responses to an anticancer drug in three stocks of ICR mice derived from three different sources.
Ji Eun SUNG ; Ji Eun KIM ; Hyun Ah LEE ; Woo Bin YUN ; Jun Young CHOI ; Mi Rim LEE ; Jin Ju PARK ; Hye Ryeong KIM ; Bo Ram SONG ; Young Suk JUNG ; Kil Soo KIM ; Dae Youn HWANG
Laboratory Animal Research 2017;33(2):187-194
		                        		
		                        			
		                        			Korl:ICR mice, established by the Korean National Institute of Food and Drug Safety Evaluation (NIFDS), are characterized based on their genetic variation, response to gastric injury, and response to constipation inducers. To compare the inhibitory responses of ICR stocks obtained from three different sources to the anticancer drug cisplatin (Cis), alterations in tumor volume, histopathological structure, and toxicity were examined in Sarcoma 180 tumor-bearing Korl:ICR, A:ICR (USA source), and B:ICR (Japan source) mice treated with low and high concentrations of Cis (L-Cis and H-Cis, respectively). Tumor size and volume were lower in H-Cis-treated mice than in L-Cis-treated mice in all three ICR stocks with no significant differences among stocks. There was a significant enhancement of the necrotizing areas in the histological structures in the L-Cis- and H-Cis-treated groups relative to that in the untreated group. The necrotizing area changes were similar in the Sarcoma 180 tumor-bearing Korl:ICR, A:ICR, and B:ICR mice. However, there were stock-bases differences in the serum biomarkers for liver and kidney toxic effects. In particular, the levels of AST, ALT and BUN increased differently in the three H-Cis-treated ICR stocks, whereas the levels of ALP and CRE were constant. Taken together, the results of the present study indicate that Korl:ICR, A:ICR, and B:ICR mice have similar overall inhibitory responses following Cis treatment of Sarcoma 180-derived solid tumors, although there were some differences in the magnitude of the toxic effects in the three ICR stocks.
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Biomarkers
		                        			;
		                        		
		                        			Cisplatin
		                        			;
		                        		
		                        			Constipation
		                        			;
		                        		
		                        			Genetic Variation
		                        			;
		                        		
		                        			Kidney
		                        			;
		                        		
		                        			Liver
		                        			;
		                        		
		                        			Mice
		                        			;
		                        		
		                        			Mice, Inbred ICR*
		                        			;
		                        		
		                        			Sarcoma
		                        			;
		                        		
		                        			Sarcoma 180
		                        			;
		                        		
		                        			Tumor Burden
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail